Adrenocortical carcinoma
T Else, AC Kim, A Sabolch, VM Raymond… - Endocrine …, 2014 - academic.oup.com
Adrenocortical carcinoma (ACC) is a rare endocrine malignancy, often with an unfavorable
prognosis. Here we summarize the knowledge about diagnosis, epidemiology …
prognosis. Here we summarize the knowledge about diagnosis, epidemiology …
Adrenocortical carcinoma: a clinician's update
M Fassnacht, R Libé, M Kroiss, B Allolio - Nature Reviews …, 2011 - nature.com
Adrenocortical carcinoma is a rare heterogeneous neoplasm with an incompletely
understood pathogenesis and a poor prognosis. Previous studies have identified …
understood pathogenesis and a poor prognosis. Previous studies have identified …
Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
M Fassnacht, G Assie, E Baudin… - Annals of …, 2020 - annalsofoncology.org
Two different primary malignancies can arise from the adrenal gland: adrenocortical
carcinoma (ACC) from the adrenal cortex and malignant phaeochromocytoma from the …
carcinoma (ACC) from the adrenal cortex and malignant phaeochromocytoma from the …
Combination chemotherapy in advanced adrenocortical carcinoma
M Fassnacht, M Terzolo, B Allolio… - … England Journal of …, 2012 - Mass Medical Soc
Background Adrenocortical carcinoma is a rare cancer that has a poor response to cytotoxic
treatment. Methods We randomly assigned 304 patients with advanced adrenocortical …
treatment. Methods We randomly assigned 304 patients with advanced adrenocortical …
European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network …
M Fassnacht, OM Dekkers, T Else… - European journal of …, 2018 - academic.oup.com
Adrenocortical carcinoma (ACC) is a rare and in most cases steroid hormone-producing
tumor with variable prognosis. The purpose of these guidelines is to provide clinicians with …
tumor with variable prognosis. The purpose of these guidelines is to provide clinicians with …
Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study
M Fassnacht, A Berruti, E Baudin, MJ Demeure… - The lancet …, 2015 - thelancet.com
Background Adrenocortical carcinoma is a rare, aggressive cancer for which few treatment
options are available. Linsitinib (OSI-906) is a potent, oral small molecule inhibitor of both …
options are available. Linsitinib (OSI-906) is a potent, oral small molecule inhibitor of both …
Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection
F Beuschlein, J Weigel, W Saeger… - The Journal of …, 2015 - academic.oup.com
Background: Recurrence of adrenocortical carcinoma (ACC) even after complete (R0)
resection occurs frequently. Objective: The aim of this study was to identify markers with …
resection occurs frequently. Objective: The aim of this study was to identify markers with …
Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification
M Fassnacht, S Johanssen, M Quinkler, P Bucsky… - Cancer, 2009 - Wiley Online Library
BACKGROUND: Adrenocortical carcinoma (ACC) is a rare malignancy, and it was only in
2004 that the International Union Against Cancer (UICC) defined TNM criteria and published …
2004 that the International Union Against Cancer (UICC) defined TNM criteria and published …
Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
A Berruti, E Baudin, H Gelderblom… - Annals of …, 2012 - annalsofoncology.org
Two different primary malignancies can arise from the adrenal gland: the adrenocortical
carcinoma (ACC) from the adrenal cortex and the malignant pheochromocytoma from the …
carcinoma (ACC) from the adrenal cortex and the malignant pheochromocytoma from the …
[HTML][HTML] Adrenocortical carcinoma: a population-based study on incidence and survival in the Netherlands since 1993
TMA Kerkhofs, RHA Verhoeven… - European Journal of …, 2013 - Elsevier
BACKGROUND: The reported annual incidence of adrenocortical carcinoma (ACC) is 0.5–
2.0 cases per million individuals. Updated population-based studies on incidence are …
2.0 cases per million individuals. Updated population-based studies on incidence are …